The diagnosis of lobular carcinoma in situ (LCIS) provokes considerable anxiety in patients
owing to misconceptions about this diagnosis. Initially LCIS was considered a premalignant …

Purpose The increased breast cancer risk conferred by a diagnosis of lobular carcinoma in
situ (LCIS) is poorly understood. Here, we review our 29-year longitudinal experience with …

Atypical lobular hyperplasia (ALH) and lobular carcinoma in situ (LCIS) represent a
spectrum of breast disease referred to as" lobular neoplasia"(LN). Although LN occurs …

Purpose Lobular carcinoma in situ (LCIS) is a marker of increased risk of breast cancer.
Current guidelines do not recommend mastectomy as a strategy for risk reduction for most …

Lobular carcinoma in situ (lobular neoplasia) is usually a clinically inapparent incidental
finding in breast biopsies, performed for an unrelated reason, in premenopausal women …

Lobular carcinoma in situ (LCIS) is a risk factor and a nonobligate precursor of breast
carcinoma. The relative risk of invasive carcinoma after classic LCIS diagnosis is …

Lobular carcinoma in situ (LCIS) is not only a relative newcomer among breast lesions, but
in its short span of 50 years in has gradually evolved from a rare form of breast cancer to …

Lobular Carcinoma in Situ: What Clinicians Need to Know Page 1 Clinical Review Lobular
Carcinotna in Situ: What Clinicians Need to Know PAUL N. GROOFF, RUBENS J. PAMIES …

Background: The finding of lobular carcinoma in situ (LCIS) in the breast has generally
prompted treatment with unilateral or bilateral mastectomy. Most experts now feel that LCIS …

Aim Lobular carcinoma in situ (LCIS) is a known risk factor for invasive breast carcinoma, but
there is increasing data indicating a possible precursor relationship. This study investigates …